Clinical Trial Update: Observational AVODART (Dutasteride) Study In Benign Prostatic Hyperplasia Subjects - OASIS

View source ↗

Summary

An observational study of dutasteride (Avodart) in men with benign prostatic hyperplasia (the OASIS trial) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia

Drugs mentioned

• Avodart (dutasteride)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Prostatic Hyperplasia | Status: COMPLETED